(Total Views: 380)
Posted On: 02/20/2018 7:50:19 AM
Post# of 72443
I'm chalking your comments and some of the other comments to inexperience with the bio sector.
The biggest potential is right where we are right now. Completing phase 2 trials. Of course the wild card right now is prurisol. Likely successful imo.
You would take an $8 - $30 buyout with a potential value of $100+?
Nothing's a sure thing, I wouldn't expect to hear anything until prurisol posts data.
The potential values are calculated by the competition. And if IPIX's science tops theirs? I'll buy your shares as this passes $8 on the way up including up-listing.
Until we see data and partnerships, this can be under valued, off radar and shake out the impatient.
Guess this is why these boards have ignore features.
The biggest potential is right where we are right now. Completing phase 2 trials. Of course the wild card right now is prurisol. Likely successful imo.
You would take an $8 - $30 buyout with a potential value of $100+?
Nothing's a sure thing, I wouldn't expect to hear anything until prurisol posts data.
The potential values are calculated by the competition. And if IPIX's science tops theirs? I'll buy your shares as this passes $8 on the way up including up-listing.
Until we see data and partnerships, this can be under valued, off radar and shake out the impatient.
Quote:
Exactly. Which is why I would vote for a $8-30 buyout if the proxy arrived at the DQ tomorrow. Eliminate all risk and give me 10-40x my money tomorrow? Absolutely. If that makes me a basher then I'll wear the badge with honor.
Go IPIX!
Guess this is why these boards have ignore features.
(3)
(0)Scroll down for more posts ▼
